Back to Results
First PageMeta Content
Pharmaceutical industry / Drug discovery / Pharmacy / Clinical research / Azure Services Platform / Cloud computing / SQL Azure / Drug development / Clinical trial / Pharmaceutical sciences / Pharmacology / Medicinal chemistry


Document Date: 2012-11-16 11:00:22

Open Document

File Size: 1,91 MB

Share Result on Facebook

Company

Molplex / Microsoft / /

Currency

USD / /

Facility

Newcastle University / /

IndustryTerm

software searches / chemical synthesis / empirical services / cloud computing treat diseases / technological solution / biological and physico-chemical properties / cloud computing resources / pharmaceutical researchers / search criteria / chemical compounds / massive computing resources / technology infrastructure / possible chemical structures / consortium discovery technology / computing / cloud computing / chemical structure / chemicals / /

MedicalCondition

Against Disease / cloud computing treat diseases / Clouds Against Disease / Windows Azure platform Clouds Against Disease / great diseases / malaria / Soon FIGHTING TROPICAL DISEASES / diseases / bacterial infection / DEVELOPMENT OF CLOUDS AGAINST DISEASE / tropical diseases / globe Clouds Against Disease / tuberculosis / /

OperatingSystem

Microsoft Windows / /

Organization

Newcastle University / Malaysian government / European Union / /

Person

Molplex Toxicity / Paul Watson / Vladimir J. Sykora / David Leahy Paul Watson Websites / Molplex Professor / Generic Worker / VENUS-C / David Leahy / /

Position

Professor of Computing / co-founder and chief operating officer / Chief Executive Officer / co-founder and chief executive officer / business model / Chief Operating Officer / professor of Computing Science / /

Product

Clouds / /

ProgrammingLanguage

SQL / /

Technology

drug discovery / VENUS-C consortium discovery technology / /

URL

windowsazure.com / /

SocialTag